Trial Profile
A retrospective, convenience sample study to evaluate the efficacy of 8 weeks of Ledipasvir/Sofosbuvir in African Americans cohort.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Apr 2018
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 18 Apr 2018 New trial record
- 07 Mar 2018 Results presented at the 25th Conference on Retroviruses and Opportunistic Infections